Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
You Mo; Yiwei Qin; Jian Shangguan; Duncan Wei; Meng Wu; Dawei Chen; Jinming Yu;
Arch Bronconeumol. 2024;60 Supl 2:S13-21
Incidence and Risk Factors for Infectious Complications of EBUS-TBNA: Prospective Multicenter Study
Pere Serra Mitjà; Filipe Gonçalves dos Santos Carvalho; Ignasi Garcia Olivé; José Sanz Santos; Jesús Jiménez López; Ana Núñez Ares; Laura Tomás López; Carmen Centeno Clemente; Rachid Tazi; Eva Castellà; Jorge Abad Capa; Antoni Rosell Gratacós; Felipe Andreo Garcia;
Arch Bronconeumol. 2023;59:84-9
PD-1 Inhibitor for a Non-Small-Cell Lung Cancer Patient With Paraneoplastic Nephropathy
Hironori Yoshida; Shigeaki Iwatsubo; Takashi Nishimura;
Arch Bronconeumol. 2021;57:311-2